Intelligence · Clinical Development
Pipeline search results
Programs matching “Vertex Pharmaceuticals” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 159 pipeline programs matching "Vertex Pharmaceuticals" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Biological/Vaccine
Vertex Pharmaceuticals (Australia) Pty.
Type 1 Diabetes
1 trial -
CTX001
Vertex Pharmaceuticals (Australia) Pty.
Beta-Thalassemia
1 trial -
CTX001-111
Vertex Pharmaceuticals (Australia) Pty.
Transfusion-dependent β-thalassemia (TDT)
1 trial -
Casgevy 4 - 13 x 10^6 cells/mL dispersion for infusion
Vertex Pharmaceuticals (Australia) Pty.
Sickle Cell Disease, Transfusion dependent thalassemia
1 trial -
ELX/TEZ/IVA
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
19 trials -
Exa-cel
Vertex Pharmaceuticals (Australia) Pty.
Sickle Cell Disease
1 trial -
IVA
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
3 trials -
Ivacaftor
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
16 trials -
LUM
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
Lumacaftor
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
6 trials -
Lumacaftor Plus Ivacaftor Combination
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation
1 trial -
Lumacaftor Plus Ivacaftor Combination
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
1 trial -
MP-424
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C
1 trial -
MP-424
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
2 trials -
Pegylated Interferon Alfa 2a
Vertex Pharmaceuticals (Australia) Pty.
Infection
1 trial -
Pegylated Interferon Alfa 2a
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
Placebo
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
1 trial -
Povetacicept
Vertex Pharmaceuticals (Australia) Pty.
Immunoglobulin A Nephropathy
1 trial -
Povetacicept
Vertex Pharmaceuticals (Australia) Pty.
Primary Membranous Nephropathy
1 trial -
Ribavirin
Vertex Pharmaceuticals (Australia) Pty.
Genotype 1 Chronic Hepatitis C
1 trial -
SUZ
Vertex Pharmaceuticals (Australia) Pty.
Acute Pain
1 trial -
Suzetrigine
Vertex Pharmaceuticals (Australia) Pty.
Diabetic Peripheral Neuropathic Pain
3 trials -
Suzetrigine (SUZ)
Vertex Pharmaceuticals (Australia) Pty.
Acute Pain
1 trial -
TEZ
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
2 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.